SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.530
+0.060 (1.73%)
At close: Apr 28, 2026, 4:00 PM EDT
3.500
-0.030 (-0.85%)
After-hours: Apr 28, 2026, 6:20 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $248.07 million as of April 28, 2026. Its market cap has increased by 2,071.26% in one year.
Market Cap
248.07M
Enterprise Value
157.43M
1-Year Change
2,071.26%
Ranking
Category
Stock Price
$3.53
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $248.07M, an increase of 89.72%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 248.07M | 39.33% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 263.22M |
| Artiva Biotherapeutics | 255.08M |
| Sol-Gel Technologies | 244.62M |
| Arcturus Therapeutics Holdings | 244.15M |
| Adagene | 243.81M |
| Orchestra BioMed Holdings | 241.69M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |